Indeed, it has been demonstrated that TLR9 stimulation combined with RT treatment leads to humoral antitumor immune responses, increases tumoral infiltration, reduces pulmonary metastases, and improves the survival in mice bearing a murine lung adenocarcinoma (Lewis lung adenocarcinoma) [44]. Here, TLR9 is linked to lung adenocarcinoma.